SGO 2023 Conference Coverage on VuMedi

 

Videos
04:53

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Updates on Advanced or Recurrent Endometrial Tumors: NGS Complements Conventional Clinical HER2 Testing

FEATURING Sarah Lee
  • 87 views
  • April 14, 2023
07:23

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 1 Trial of Botensilimab + Balstilimab in Patients With Recurrent Platinum Refractory/Resistant Ovarian Cancer

FEATURING Bruno Bockorny
  • 86 views
  • April 14, 2023
  • 2
11:32

SGO 2023 Conference Coverage on VuMedi

SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum

FEATURING Brian Slomovitz
  • 401 views
  • April 14, 2023
  • 1
11:01

SGO 2023 Conference Coverage on VuMedi

Molecular Classification of Mixed Histology Endometrial Cancers

FEATURING Paulina Haight
  • 153 views
  • April 14, 2023
06:48

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 3 UP-NEXT Trial: Upifitamab Rilsodotin, a NaPi2b-Directed ADC, in Platinum-Sensitive Recurrent Ovarian Cancer

FEATURING Debra Richardson
  • 117 views
  • April 14, 2023
11:02

SGO 2023 Conference Coverage on VuMedi

Chemoradiation for Stage IB3 Cervical Cancer

FEATURING Jyoti Mayadev
  • 551 views
  • April 5, 2023
  • 3
11:14

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Placebo-Controlled Randomized Phase 3 Trial: Dostarlimab in Combination With Chemo for the Treatment of Primary Advanced or Recurrent Endometrial Cancer

FEATURING Mansoor Raza Mirza
  • 250 views
  • April 5, 2023
  • 2
09:07

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Primary Ovarian Cancer Patients: Health-Related Quality of Life After Cytoreductive Surgery +/- HIPEC

FEATURING Vadim Gushchin
  • 46 views
  • April 4, 2023
06:09

SGO 2023 Conference Coverage on VuMedi

SGO 2023 Sentinel Lymph Biopsy vs. Full Lymphadenectomy in Endometrial Cancer: SEER Database Analysis

FEATURING Chen Nahshon
  • 171 views
  • April 4, 2023